MLTX

Analysts review MoonLake Immunotherapeutics’s rating

Anna Perez

In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.